Connor, Clark & Lunn Investment Management (CC&L)’s Evolent Health EVH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Buy	227,708 +160,407	+238%	+$615K	﹤0.01%	1135
2026 Q1	$153K	Buy	67,301 +53,979	+405%	+$171K	﹤0.01%	1493
2025 Q4	$53.3K	Buy	+13,322	New	+$74.1K	﹤0.01%	1499
2025 Q3	–	Sell	-403,677	Closed	-$4.55M	–	1563
2025 Q2	$4.55M	Buy	403,677 +178,307	+79%	+$1.64M	0.02%	601
2025 Q1	$2.13M	Buy	225,370 +154,753	+219%	+$1.56M	0.01%	713
2024 Q4	$794K	Buy	+70,617	New	+$1.24M	﹤0.01%	1014
2022 Q4	–	Sell	-24,165	Closed	-$868K	–	1281
2022 Q3	$868K	Buy	+24,165	New	+$851K	0.01%	687
2016 Q3	–	Sell	-11,400	Closed	-$219K	–	857
2016 Q2	$219K	Buy	+11,400	New	+$157K	﹤0.01%	732

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s EVH Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Evolent Health (EVH) stake by 238% in Q2 2026, buying an estimated $615K and bringing the position to 227,708 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in EVH in Q2 2016 and has held it in 8 quarters since. The position peaked at $4.55M in Q2 2025. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 227,708 shares of Evolent Health worth $1.23M as of Q2 2026.
Connor, Clark & Lunn Investment Management (CC&L) bought 160,407 Evolent Health shares in Q2 2026, an estimated $615K.
Evolent Health made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1135 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Evolent Health in Q2 2016 and has held it in 8 quarters since.
Connor, Clark & Lunn Investment Management (CC&L)'s Evolent Health position peaked at $4.55M in Q2 2025.
199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.